Evidence map›Paper›PMID 40477452›Full record

ArticleFundamental research2022

AI-aided on-chip nucleic acid assay for smart diagnosis of infectious disease.

Hao Sun, Linghu Xiong, Yi Huang, Xinkai Chen, Yongjian Yu, Shaozhen Ye, Hui Dong, Yuan Jia, Wenwei Zhang

Abstract read
In one paragraph

Article in Fundamental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Advances in flexible graphene field-effect transistors for biomolecule sensing.Frontiers in bioengineering and biotechnology · 2023
    Review
  12. A portable system for economical nucleic acid amplification testing.Frontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hao SunSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, China.
Linghu XiongSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, China.
Yi HuangProvincial Clinical College, Fujian Medical University, Fuzhou 350001, China.
Xinkai ChenSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, China.
Yongjian YuSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, China.
Shaozhen YeCollege of Mathematics and Computer Science, Fuzhou University, Fuzhou 350116, China.
Hui DongSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350116, China.
Yuan JiaCollege of New Materials and New Energies, Shenzhen Technology University, Shenzhen 518118, China.
Wenwei ZhangSino-German College of Intelligent Manufacturing, Shenzhen Technology University, Shenzhen 518118, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global pandemics such as COVID-19 have resulted in significant global social and economic disruption. Although polymerase chain reaction (PCR) is recommended as the standard test for identifying the SARS-CoV-2, conventional assays are time-consuming. In parallel, although artificial intelligence (AI) has been employed to contain the disease, the implementation of AI in PCR analytics, which may enhance the cognition of diagnostics, is quite rare. The information that the amplification curve reveals can reflect the dynamics of reactions. Here, we present a novel AI-aided on-chip approach by integrating deep learning with microfluidic paper-based analytical devices (µPADs) to detect synthetic RNA templates of the SARS-CoV-2 ORF1ab gene. The µPADs feature a multilayer structure by which the devices are compatible with conventional PCR instruments. During analysis, real-time PCR data were synchronously fed to three unsupervised learning models with deep neural networks, including RNN, LSTM, and GRU. Of these, the GRU is found to be most effective and accurate. Based on the experimentally obtained datasets, qualitative forecasting can be made as early as 13 cycles, which significantly enhances the efficiency of the PCR tests by 67.5% (∼40 min). Also, an accurate prediction of the end-point value of PCR curves can be obtained by GRU around 20 cycles. To further improve PCR testing efficiency, we also propose AI-aided dynamic evaluation criteria for determining critical cycle numbers, which enables real-time quantitative analysis of PCR tests. The presented approach is the first to integrate AI for on-chip PCR data analysis. It is capable of forecasting the final output and the trend of qPCR in addition to the conventional end-point Cq calculation. It is also capable of fully exploring the dynamics and intrinsic features of each reaction. This work leverages methodologies from diverse disciplines to provide perspectives and insights beyond the scope of a single scientific field. It is universally applicable and can be extended to multiple areas of fundamental research.

Indexed as

Deep learningInfectious disease diagnosisMicrofluidicsPolymerase chain reactionReal-time predictive analytics

Identifiers

PMID40477452
PMCPMC8712671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.